Cargando…

Evolution of Public Health Human Papillomavirus Immunization Programs in Canada

Background: Since 2007, all Canadian provinces and territories have had a publicly funded program for vaccination against human papillomavirus (HPV) infection. The objective of this study was to describe the evolution of these vaccination programs. Methods: This was a targeted literature review of p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goyette, Alexandra, Yen, Glorian P., Racovitan, Voica, Bhangu, Parambir, Kothari, Smita, Franco, Eduardo L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985769/ https://www.ncbi.nlm.nih.gov/pubmed/33617515 http://dx.doi.org/10.3390/curroncol28010097

Ejemplares similares

Human papillomavirus variants among Inuit women in northern Quebec, Canada
por: Gauthier, Barbara, et al.
Publicado: (2015)

Hands-On Training in a Digital World: A Novel Simulation-Based Virtual Training Program for Placement and Removal of the Subdermal Contraceptive Implant
por: Black, Amanda, et al.
Publicado: (2022)

The impact of publicly funded immunization programs on human papillomavirus vaccination in boys and girls: An observational study
por: Shapiro, Gilla K., et al.
Publicado: (2021)

Persistence of human papillomavirus 16, 18 and 52 variants in Inuit women from Northern Quebec, Canada
por: Gauthier, Barbara, et al.
Publicado: (2019)

Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis
por: Kulasingam, Shalini L, et al.
Publicado: (2009)

Knowledge and Understanding of the Safety and Efficacy Aspects of BRIDION(®) Among Canadian Anesthesiologists
por: Stemhagen, Annette, et al.
Publicado: (2020)

Hands-on Training in a Virtual World: Novel Simulation-based Virtual Training for Subdermal Contraceptive Implant Placement and Removal
por: Black, Amanda, et al.
Publicado: (2022)

Evaluating human papillomavirus vaccination programs in Canada: should provincial healthcare pay for voluntary adult vaccination?
por: Llamazares, Marco, et al.
Publicado: (2008)

The prevalence of human papillomavirus and its impact on cervical dysplasia in Northern Canada
por: Jiang, Ying, et al.
Publicado: (2013)

Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis
por: Daniels, Vincent, et al.
Publicado: (2021)

An Unsupervised Smart App–Optimized HIV Self-Testing Program in Montreal, Canada: Cross-Sectional Study
por: Pant Pai, Nitika, et al.
Publicado: (2018)

Evaluating Human Papillomavirus Vaccination Programs
por: Taira, Al V., et al.
Publicado: (2004)

Public–private partnership alternative for a national pharmacare program in Canada
por: Nauenberg, Eric, et al.
Publicado: (2023)

A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada
por: Insinga, Ralph P., et al.
Publicado: (2016)

Social equity in Human Papillomavirus vaccination: a natural experiment in Calgary Canada
por: Musto, Richard, et al.
Publicado: (2013)

Human Papillomavirus Vaccination Uptake in Canada: A Systematic Review and Meta-analysis
por: Bird, Yelena, et al.
Publicado: (2017)

Public health in Canada: Evolution, meaning and a new paradigm for respiratory therapy
por: West, Andrew J
Publicado: (2013)

Evolution of public health policy on healthcare self-management: the case of Ontario, Canada
por: Gauthier-Beaupré, Amélie, et al.
Publicado: (2023)

Individual and Public-Program Adaptation: Coping with Heat Waves in Five Cities in Canada
por: Alberini, Anna, et al.
Publicado: (2011)

Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada
por: Severini, Alberto, et al.
Publicado: (2013)

Barriers and facilitators in uptake of human papillomavirus vaccine across English Canada: A review
por: Khan, Amal, et al.
Publicado: (2023)

Ancient Evolution and Dispersion of Human Papillomavirus 58 Variants
por: Chen, Zigui, et al.
Publicado: (2017)

The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses
por: Bernard, Hans-Ulrich
Publicado: (2005)

Human Papillomavirus and Cancers
por: Tornesello, Maria Lina, et al.
Publicado: (2020)

Women’s intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program
por: Smith, Laurie W, et al.
Publicado: (2014)

Impact of a Publicly Funded Herpes Zoster Immunization Program on the Burden of Disease in Ontario, Canada: A Population-based Study
por: Martins, Diana, et al.
Publicado: (2020)

Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009–2013
por: Cameron, Ross L., et al.
Publicado: (2016)

Current Status of Human Papillomavirus Infection and Introduction of Vaccination to the National Immunization Program in Korea: an Overview
por: Kim, Min-A, et al.
Publicado: (2018)

Resumption of active recommendation of the human papillomavirus vaccine in Japan and future challenges for the National Immunization Program
por: Ujiie, Mugen
Publicado: (2022)

Public health impact of a novel smoking cessation outreach program in Ontario, Canada
por: Selby, Peter, et al.
Publicado: (2018)

Continuity of routine immunization programs in Canada during the COVID-19 pandemic
por: Sell, Hannah, et al.
Publicado: (2021)

Public awareness of the association between human papillomavirus and oropharyngeal cancer
por: Verhees, Femke, et al.
Publicado: (2021)

Estimating the prevalence of non-cervical human papillomavirus infection in mainland China (PROGRESS-Plus): protocol of a national cross-sectional study
por: Wang, Wei, et al.
Publicado: (2023)

COVID-19 IMPACT ON HUMAN PAPILLOMAVIRUS IMMUNIZATION PROGRAM IN PERU: MODELLING TIME AND CATCH-UP RATES TO CLOSE THE IMMUNIZATION GAP
por: Parellada, C., et al.
Publicado: (2023)

Papillomaviruses: Viral evolution, cancer and evolutionary medicine
por: Bravo, Ignacio G., et al.
Publicado: (2015)

Origin and evolution of papillomavirus (onco)genes and genomes
por: Willemsen, Anouk, et al.
Publicado: (2019)

Synonymous nucleotide changes drive papillomavirus evolution
por: King, Kelly M., et al.
Publicado: (2022)

Immune Dysregulation in Patients Persistently Infected with Human Papillomaviruses 6 and 11
por: Lucs, Alexandra V., et al.
Publicado: (2015)

Anal Human Papillomavirus Prevalence Among Vaccinated and Unvaccinated Gay, Bisexual, and Other Men Who Have Sex With Men in Canada
por: Chambers, Catharine, et al.
Publicado: (2022)

Can an HIVSmart! App-optimized Self-Testing Strategy be Operationalized in Canada?
por: Pai, Nitika Pant, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1qnp37lq25cqed6q07ij71t8rr